SCM
UTHR icon

Soleus Capital Management’s United Therapeutics UTHR Stock Holding History

Soleus Capital Management’s Portfolio UTHR Stock Details UTHR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$111M Buy
187,187
+127,187
+212% +$63.3M 4.5% 6
2025
Q4 		$29.2M Sell
60,000
-90,000
-60% -$41.9M 1.08% 24
2025
Q3 		$62.9M Sell
150,000
-59,794
-29% -$20.1M 3.17% 7
2025
Q2 		$60.3M Buy
209,794
+54,400
+35% +$16.3M 3.99% 5
2025
Q1 		$47.9M Buy
155,394
+46,000
+42% +$15.8M 3.45% 8
2024
Q4 		$38.6M Buy
109,394
+7,500
+7% +$2.76M 2.43% 13
2024
Q3 		$36.5M Sell
101,894
-39,605
-28% -$13.4M 2.83% 9
2024
Q2 		$45.1M Sell
141,499
-118,250
-46% -$31.3M 3.98% 3
2024
Q1 		$59.7M Buy
259,749
+10,300
+4% +$2.32M 4.43% 2
2023
Q4 		$54.9M Sell
249,449
-37,716
-13% -$8.69M 6.09% 2
2023
Q3 		$64.9M Buy
287,165
+44,430
+18% +$10.2M 5.98% 2
2023
Q2 		$53.6M Buy
242,735
+106,500
+78% +$23.6M 5.96% 1
2023
Q1 		$30.5M Buy
136,235
+7,967
+6% +$1.96M 3.16% 7
2022
Q4 		$35.7M Sell
128,268
-106,591
-45% -$26.9M 5.12% 3
2022
Q3 		$49.2M Sell
234,859
-60,682
-21% -$13.6M 6.68% 1
2022
Q2 		$69.6M Sell
295,541
-10,309
-3% -$2.1M 10.86% 1
2022
Q1 		$54.9M Buy
305,850
+141,550
+86% +$27M 7.08% 2
2021
Q4 		$35.5M Buy
164,300
+62,500
+61% +$12.3M 3.55% 6
2021
Q3 		$18.8M Buy
+101,800
New +$20.1M 2.93% 11

Other funds holding UTHR

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return

Soleus Capital Management's UTHR Position: Q1 2026 in Review

Soleus Capital Management increased its United Therapeutics (UTHR) stake by 212% in Q1 2026, buying an estimated $63.3M and bringing the position to 187,187 shares worth $111M. The position accounts for 4.5% of the portfolio, ranked #6.

Soleus Capital Management first reported a position in UTHR in Q3 2021 and has held it in 19 quarters since. 850 funds tracked by Wall St. Rank hold UTHR as of Q1 2026.

  • Soleus Capital Management held 187,187 shares of United Therapeutics worth $111M as of Q1 2026.
  • Soleus Capital Management bought 127,187 United Therapeutics shares in Q1 2026, an estimated $63.3M.
  • United Therapeutics made up 4.5% of Soleus Capital Management's portfolio in Q1 2026, its #6 holding.
  • Soleus Capital Management first reported a position in United Therapeutics in Q3 2021 and has held it in 19 quarters since.
  • 850 funds tracked by Wall St. Rank held United Therapeutics as of Q1 2026.

Based on Soleus Capital Management's 13F filing for Q1 2026, filed 14 May 2026.